Latest News in the pharma Industry

Policy & Regulation

FDA approves Allergan's Rhofade cream, 1% for persistent facial erythema

FDA approves Allergan's Rhofade cream, 1% for persistent facial erythema

19 Jan 2017

Once-daily treatment reduces persistent facial erythema associated with rosacea through 12 hours.

Read more 
Suliqua approved in the EU for the treatment of adults with type 2 diabetes

Suliqua approved in the EU for the treatment of adults with type 2 diabetes

17 Jan 2017

Suliqua will be delivered in two pre-filled SoloSTAR pens, providing different dosing options that may help answer individual market and patient insulin needs.

Read more 
Tesaro receives CRL for rolapitant IV from FDA

Tesaro receives CRL for rolapitant IV from FDA

15 Jan 2017

No concerns raised by FDA related to the rolapitant IV efficacy or safety profile and additional clinical studies are not required.

Read more 
New-generation mealtime insulin approved in Europe

New-generation mealtime insulin approved in Europe

14 Jan 2017

Novo Nordisk to launch Fiasp in first half of 2017.

Read more 
VivaGel BV granted QIDP and Fast Track designation by FDA

VivaGel BV granted QIDP and Fast Track designation by FDA

14 Jan 2017

Product receives designations for both the BV treatment and prevention indications.

Read more 
FDA grants Fast-Track Designation to RHB-104 for nontuberculous mycobacteria infections

FDA grants Fast-Track Designation to RHB-104 for nontuberculous mycobacteria infections

12 Jan 2017

RHB-104 is a proprietary and potentially groundbreaking antibiotic combination therapy in oral capsule formulation.

Read more 
US Court of Appeals rules in Lilly's favour on Alimta vitamin regimen patent

US Court of Appeals rules in Lilly's favour on Alimta vitamin regimen patent

12 Jan 2017

If the patent is ultimately upheld through all remaining challenges, Alimta would maintain US exclusivity until May 2022.

Read more 
FDA accepts BLA for Mylan and Biocon's proposed biosimilar trastuzumab

FDA accepts BLA for Mylan and Biocon's proposed biosimilar trastuzumab

11 Jan 2017

If approved, MYL-1401O has potential to be the first biosimilar trastuzumab in the US.

Read more 
Cardinal Health reaches $20 million settlement with West Virginia

Cardinal Health reaches $20 million settlement with West Virginia

9 Jan 2017

Company collaborating with all participants in the pharma supply chain to tackle to the epidemic of prescription drug abuse.

Read more 
FDA accepts for filing sNDA for Liletta 52 mg

FDA accepts for filing sNDA for Liletta 52 mg

4 Jan 2017

Application seeks to extend duration of use up to 4 years for Liletta.

Read more 
BioNet receives Thai FDA approval of the world's only available recombinant monovalent acellular Pertussis vaccine

BioNet receives Thai FDA approval of the world's only available recombinant monovalent acellular Pertussis vaccine

29 Dec 2016

BioNet's vaccine is the first recombinant monovalent Pertussis vaccine in the world to receive a MAA for booster indication in adolescents and adults.

Read more 
Positive Phase III results of Genentech’s investigational medicine Ocrevus

Positive Phase III results of Genentech’s investigational medicine Ocrevus

28 Dec 2016

Ocrevus is the first and only investigational medicine to show superior efficacy versus comparators in both relapsing and primary progressive multiple sclerosis in clinical studies.

Read more